Literature DB >> 1451944

Magnetic resonance imaging of the kidney in type 1 (insulin-dependent) diabetes mellitus.

R Mangili1, S Sironi, G Rankel, M Makarovic, G Zerbini, A Del Maschio, G Pozza.   

Abstract

Reductions in the physiological cortical to medullary signal intensity ratio are found in magnetic resonance scans of the kidney in non-diabetic glomerular disease. Whether this abnormality can also characterise patients with Type 1 (insulin-dependent) diabetes mellitus and nephropathy is not known. We measured the cortical to medullary signal intensity ratio in magnetic resonance images of the kidney in 34 patients with Type 1 diabetes (ten with either clinical proteinuria or raised serum creatinine or both, nine with microalbuminuria, seven with normal urinary albumin excretion and long duration of diabetes and eight with Type 1 diabetes of short duration). The cortical to medullary signal intensity ratio showed a trend to cluster at lower values in the normoalbuminuric patients with normal serum creatinine rather than in the nine healthy individuals, independent of Type 1 diabetes duration (1.47 +/- 0.06 and 1.41 +/- 0.13 vs 1.63 +/- 0.16; five groups Scheffé F-test p = 0.05-0.1). Among the Type 1 diabetic patients, significant reductions in the cortical to medullary signal intensity ratio characterised overt nephropathy (1.19 +/- 0.15, p less than 0.05 vs all groups), but not microalbuminuria (1.47 +/- 0.13, p = NS), concomitantly with low glomerular filtration rate and elevated fractional excretion of uric acid, but independent of glycaemic control. The determinants of the renal cortical to medullary signal intensity ratio in Type 1 diabetes are uncertain. Reductions in the cortical to medullary signal intensity ratio may be a late finding in diabetic nephropathy, and parallel the accompanying impairment in kidney haemodynamics.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451944     DOI: 10.1007/bf00401433

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  [Diagnostic value of the cortico-medullary contrast on dynamic CT and MRI in chronic renal parenchymal diseases].

Authors:  H Otsuji; J Tushima; S Hirohashi; S Itoh; S Iwasaki; H Ohishi; H Uchida; M Maeda; K Yoshiya; T Matsuo
Journal:  Rinsho Hoshasen       Date:  1989-03

Review 2.  Central role of sodium in hypertension in diabetic subjects.

Authors:  P Weidmann; P Ferrari
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

3.  Incipient nephropathy in type 1 (insulin-dependent) diabetes.

Authors:  E R Mathiesen; B Oxenbøll; K Johansen; P A Svendsen; T Deckert
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

4.  The diagnostic value of renal cortex-to-medulla contrast on magnetic resonance images.

Authors:  F Terrier; H Hricak; E Justich; G C Dooms; W Grodd
Journal:  Eur J Radiol       Date:  1986-05       Impact factor: 3.528

5.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

6.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

7.  Tubular Na+ handling in type I insulin-dependent diabetics during saline and ketone body infusion.

Authors:  A Semplicini; P Angeli; R Nosadini; R Trevisan; P Fioretto; A Doria; E Rigon; B Sama
Journal:  Diabetes Res       Date:  1989-06

Review 8.  Morphology of diabetic glomerulopathy and relationship to hypertension.

Authors:  R Osterby; H H Parving; G Nyberg; E Hommel; S M Mauer; M W Steffes
Journal:  Diabete Metab       Date:  1989

9.  Monitoring glomerular function in diabetic nephropathy. A prospective study.

Authors:  G C Viberti; R W Bilous; D Mackintosh; H Keen
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.